These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17349461)

  • 1. Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis.
    Anzueto A; Bishai WR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):31S-38S. PubMed ID: 17349461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefdinir: an oral alternative to parenteral cephems.
    Chatterjee A; Moland ES; Thomson KS
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):259-64. PubMed ID: 15808317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
    Lee MY; Ko KS; Oh WS; Park S; Lee JY; Baek JY; Suh JY; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2006 Jul; 28(1):14-8. PubMed ID: 16777383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
    Sader HS; Jones RN
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
    Sader HS; Jacobs MR; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
    Dever LL; Shashikumar K; Johanson WG
    Expert Opin Investig Drugs; 2002 Jul; 11(7):911-25. PubMed ID: 12084002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
    Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
    Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK; Triller DM; Yong CS; Lodise TP
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbation of chronic bronchitis. Guidelines for antibiotic selection.
    Schwarzmann SW
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):25-9. PubMed ID: 19667546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbation of chronic bronchitis: a primary care consensus guideline.
    Brunton S; Carmichael BP; Colgan R; Feeney AS; Fendrick AM; Quintiliani R; Scott G
    Am J Manag Care; 2004 Oct; 10(10):689-96. PubMed ID: 15521160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro characterization of cefditoren, a new oral cephalosporin.
    Felmingham D; Robbins MJ; Ghosh G; Bhogal H; Mehta MD; Leakey A; Clark S; Dencer CA; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1994; 20(4):127-47. PubMed ID: 7813385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute exacerbations of chronic bronchitis: antibiotic therapy.
    Anzueto A
    Semin Respir Crit Care Med; 2000; 21(2):97-106. PubMed ID: 16088723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of oral cephalosporins in the treatment of acute otitis media in children.
    Brook I
    Int J Antimicrob Agents; 2004 Jul; 24(1):18-23. PubMed ID: 15225855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis.
    Sethi S; Anzueto A; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2005 Mar; 4():5. PubMed ID: 15755326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
    Barriere SL
    Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.